戻る Agenda
Session 5: Paradigm shift in Clinical Trials
Session Chair(s)
Vicky Hsu
Senior Vice President, Head of Project Leadership and Biotech Operations Asia
Parexel International, Singapore
Senthil Sockalingam
M.D, Head of IQVIA Biotech, JAPAC, Chief Medical Officer, IQVIA, APAC
IQVIA, Singapore
The COVID-19 pandemic and the maturation of technology has accelerated a much needed second order change in the way we conduct clinical trials and generate data to answer important healthcare questions. In this session we will learn about these key changes and discuss the practicalities of converting them to reality with experts from the various part of the research ecosystem.
Speaker(s)
Pandemic Setting for Trials
Daniel Tan, MD, MBA
Health Sciences Authority, Singapore
Director, Policy Legislation and Operations, Health Products Regulation Group
New Approaches in Clinical Trials
Jeff Ten
Paraxel, United States
Director Project Management & Delivery Regional Head
The Role of RWE in a Changing Evidence Landscape
Nora Kleinman
IQVIA, United States
Associate Principal, Real World Solutions, Database Analytics – APAC